Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
CRISPR-Cas9: a preclinical and clinical perspective for the treatment of human diseases
At present, the idea of genome modification has revolutionized the modern therapeutic
research era. Genome modification studies have traveled a long way from gene …
research era. Genome modification studies have traveled a long way from gene …
Antibiotic therapy as personalized medicine–general considerations and complicating factors
The discovery of antibiotic drugs is considered one of the previous century's most important
medical discoveries (Medicine's 10 greatest discoveries. New Haven, CT: Yale University …
medical discoveries (Medicine's 10 greatest discoveries. New Haven, CT: Yale University …
[HTML][HTML] The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects
S Van den Bossche, E De Broe… - European …, 2021 - publications.ersnet.org
Chronic airway colonisation by Pseudomonas aeruginosa, a hallmark of cystic fibrosis (CF)
lung disease, is associated with increased morbidity and mortality and despite aggressive …
lung disease, is associated with increased morbidity and mortality and despite aggressive …
[HTML][HTML] Personalized medicine based on nasal epithelial cells: comparative studies with rectal biopsies and intestinal organoids
As highly effective CFTR modulator therapies (HEMT) emerge, there is an unmet need to
find effective drugs for people with CF (PwCF) with ultra-rare mutations who are too few for …
find effective drugs for people with CF (PwCF) with ultra-rare mutations who are too few for …
Current and future therapeutic approaches of exocrine pancreatic insufficiency in children with cystic fibrosis in the era of personalized medicine
This review presents current updates of pancreatic enzyme replacement therapy in children
with cystic fibrosis based on literature published in the last decade and some special …
with cystic fibrosis based on literature published in the last decade and some special …
Cystic fibrosis: Physiopathology and the latest pharmacological treatments
Cystic fibrosis (CF) is a lethal autosomal recessive genetic disease, caused by a mutation in
the cystic fibrosis transmembrane conductance regulator gene (CFTR), which primarily …
the cystic fibrosis transmembrane conductance regulator gene (CFTR), which primarily …
Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients
Whenever Pseudomonas aeruginosa is cultured from cystic fibrosis (CF) patient airways, the
primary goal is eradication by antibiotic therapy. Success is defined by≥ 6 months of …
primary goal is eradication by antibiotic therapy. Success is defined by≥ 6 months of …
Evolving nutritional needs in cystic fibrosis
T Frantzen, S Barsky, G LaVecchia, M Marowitz… - Life, 2023 - mdpi.com
The course of cystic fibrosis (CF) as a nutritional illness is diverging since the introduction of
highly effective modulator therapy, leading to more heterogeneous phenotypes of the …
highly effective modulator therapy, leading to more heterogeneous phenotypes of the …
[HTML][HTML] Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection
Biofilm infections are tolerant to the host responses and recalcitrance to antibiotic drugs and
disinfectants. The induced host-specific innate and adaptive immune responses by …
disinfectants. The induced host-specific innate and adaptive immune responses by …
[HTML][HTML] In vivo demonstration of Pseudomonas aeruginosa biofilms as independent pharmacological microcompartments
L Christophersen, FA Schwartz, CJ Lerche… - Journal of Cystic …, 2020 - Elsevier
Background Pseudomonas aeruginosa is difficult to eradicate from the lungs of cystic
fibrosis (CF) patients due to biofilm formation. Organs and blood are independent …
fibrosis (CF) patients due to biofilm formation. Organs and blood are independent …